Utah Medical Products UTMD Effect of exchange rate changes on cash, cash equivalents and restricted cash
Effect of exchange rate changes on cash, cash equivalents and restricted cash at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's effect of exchange rate changes on cash, cash equivalents and restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's effect of exchange rate changes on cash, cash equivalents and restricted cash?
- Utah Medical Products (UTMD) reported effect of exchange rate changes on cash, cash equivalents and restricted cash of -$212K in Q1 2026.
- How has Utah Medical Products's effect of exchange rate changes on cash, cash equivalents and restricted cash changed year-over-year?
- Utah Medical Products's effect of exchange rate changes on cash, cash equivalents and restricted cash decreased by 169.1% year-over-year, from $307K to -$212K.
- What does effect of exchange rate changes on cash, cash equivalents and restricted cash mean?
- This metric represents the impact of fluctuations in foreign currency exchange rates on the reported value of cash and cash equivalent balances held in non-functional currencies. It reflects the non-operating gain or loss resulting from the translation of international cash holdings into the reporting currency at period-end rates. Monitoring this helps investors distinguish between actual cash flow generation and accounting adjustments due to currency volatility.